HALOPERIDOL LACTATE

HALOPERIDOL LACTATE was reported 24939 times

These side effects are most commonly reported by patients taking HALOPERIDOL LACTATE:

# Side effect Count
0 DRUG INEFFECTIVE 2190
1 DRUG INTERACTION 1732
2 NEUROLEPTIC MALIGNANT SYNDROME 1677
3 OFF LABEL USE 1441
4 EXTRAPYRAMIDAL DISORDER 1271
5 WEIGHT INCREASED 1230
6 TOXICITY TO VARIOUS AGENTS 1134
7 AGITATION 895
8 SOMNOLENCE 843
9 CONDITION AGGRAVATED 836
10 PYREXIA 829
11 DELIRIUM 791
12 CONFUSIONAL STATE 769
13 DEATH 743
14 VOMITING 740
15 TREMOR 707
16 NAUSEA 685
17 ELECTROCARDIOGRAM QT PROLONGED 683
18 DYSTONIA 653
19 TACHYCARDIA 651
20 SEDATION 650
21 PSYCHOTIC DISORDER 648
22 AKATHISIA 634
23 AGGRESSION 599
24 HYPOTENSION 597
25 PNEUMONIA 585
26 SUICIDE ATTEMPT 584
27 DIARRHOEA 578
28 ANXIETY 573
29 DYSPNOEA 560
30 NEUTROPENIA 553
31 FATIGUE 550
32 FALL 545
33 PRODUCT USE IN UNAPPROVED INDICATION 530
34 SCHIZOPHRENIA 524
35 OVERDOSE 517
36 ACUTE KIDNEY INJURY 507
37 INSOMNIA 479
38 COMPLETED SUICIDE 463
39 HALLUCINATION 461
40 CATATONIA 455
41 HYPERTENSION 454
42 CARDIAC ARREST 450
43 RHABDOMYOLYSIS 450
44 TREATMENT NONCOMPLIANCE 450
45 MALAISE 449
46 CONSTIPATION 442
47 LEUKOPENIA 437
48 BLOOD CREATINE PHOSPHOKINASE INCREASED 432
49 HALLUCINATION, AUDITORY 430
50 MUSCLE RIGIDITY 424
51 PARKINSONISM 413
52 HYPONATRAEMIA 408
53 DELUSION 399
54 DEPRESSED LEVEL OF CONSCIOUSNESS 391
55 RESPIRATORY FAILURE 388
56 SUICIDAL IDEATION 384
57 TARDIVE DYSKINESIA 384
58 RESTLESSNESS 373
59 DEPRESSION 372
60 PULMONARY EMBOLISM 370
61 DYSPHAGIA 361
62 DIZZINESS 359
63 DYSKINESIA 358
64 ASTHENIA 357
65 SEIZURE 355
66 HYPERHIDROSIS 344
67 LOSS OF CONSCIOUSNESS 339
68 SALIVARY HYPERSECRETION 337
69 GENERAL PHYSICAL HEALTH DETERIORATION 324
70 BRADYCARDIA 317
71 SEROTONIN SYNDROME 316
72 RENAL FAILURE 313
73 ABDOMINAL PAIN 312
74 COMA 309
75 INTENTIONAL OVERDOSE 308
76 SEPSIS 306
77 HEADACHE 305
78 DRUG ABUSE 304
79 PAIN 300
80 WEIGHT DECREASED 298
81 GAIT DISTURBANCE 295
82 COGNITIVE DISORDER 294
83 PNEUMONIA ASPIRATION 294
84 THROMBOCYTOPENIA 292
85 DYSARTHRIA 283
86 ABNORMAL BEHAVIOUR 282
87 DECREASED APPETITE 273
88 ANAEMIA 265
89 CARDIO-RESPIRATORY ARREST 261
90 DISORIENTATION 260
91 WHITE BLOOD CELL COUNT DECREASED 258
92 HYPERPROLACTINAEMIA 257
93 PSYCHOMOTOR HYPERACTIVITY 254
94 LETHARGY 252
95 MENTAL IMPAIRMENT 252
96 DIABETES MELLITUS 245
97 MENTAL STATUS CHANGES 244
98 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 243
99 URINARY TRACT INFECTION 239
100 WHITE BLOOD CELL COUNT INCREASED 239
101 MUSCULOSKELETAL STIFFNESS 236
102 IRRITABILITY 229
103 URINARY RETENTION 227
104 HYPOTHERMIA 223
105 SPEECH DISORDER 223
106 DEHYDRATION 222
107 PLATELET COUNT DECREASED 220
108 ALTERED STATE OF CONSCIOUSNESS 216
109 MANIA 216
110 ENCEPHALOPATHY 205
111 DRUG HYPERSENSITIVITY 203
112 TORSADE DE POINTES 203
113 OBSESSIVE-COMPULSIVE DISORDER 202
114 CHEST PAIN 200
115 UNRESPONSIVE TO STIMULI 200
116 INCREASED APPETITE 198
117 MYOCARDITIS 197
118 RASH 197
119 BLOOD CREATININE INCREASED 196
120 HOSPITALISATION 196
121 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 193
122 LEUKOCYTOSIS 192
123 OEDEMA PERIPHERAL 192
124 PRURITUS 191
125 THERAPY NON-RESPONDER 191
126 MENTAL DISORDER 187
127 ALANINE AMINOTRANSFERASE INCREASED 185
128 HYPOXIA 185
129 DISTURBANCE IN ATTENTION 184
130 TREATMENT FAILURE 184
131 MYOCLONUS 183
132 COUGH 182
133 DRUG LEVEL INCREASED 181
134 RENAL IMPAIRMENT 181
135 MEDICATION ERROR 180
136 EUPHORIC MOOD 179
137 HYPOKALAEMIA 179
138 PARANOIA 179
139 NEUTROPHIL COUNT DECREASED 178
140 SYNCOPE 175
141 VISION BLURRED 174
142 FEELING ABNORMAL 173
143 HAEMOGLOBIN DECREASED 173
144 NEUTROPHIL COUNT INCREASED 173
145 DRUG WITHDRAWAL SYNDROME 172
146 ASPARTATE AMINOTRANSFERASE INCREASED 170
147 INTENTIONAL SELF-INJURY 170
148 MEMORY IMPAIRMENT 168
149 ATRIAL FIBRILLATION 165
150 HYPERTHERMIA 164
151 INTENTIONAL PRODUCT MISUSE 163
152 OBESITY 163
153 CARDIAC FAILURE 162
154 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 158
155 CHRONIC KIDNEY DISEASE 156
156 DISEASE PROGRESSION 155
157 PRODUCT USE ISSUE 154
158 CONVULSION 153
159 DISINHIBITION 153
160 SEPTIC SHOCK 153
161 C-REACTIVE PROTEIN INCREASED 150
162 URINARY INCONTINENCE 150
163 INCORRECT DOSE ADMINISTERED 149
164 INFECTION 149
165 WITHDRAWAL SYNDROME 147
166 ARRHYTHMIA 146
167 DRUG INTOLERANCE 146
168 MATERNAL EXPOSURE DURING PREGNANCY 145
169 NEUROPATHY PERIPHERAL 145
170 COVID-19 144
171 BLOOD GLUCOSE INCREASED 142
172 DRUG RESISTANCE 142
173 PLEURAL EFFUSION 142
174 PRESCRIBED OVERDOSE 141
175 RENAL FAILURE ACUTE 141
176 FOETAL EXPOSURE DURING PREGNANCY 140
177 HEART RATE INCREASED 140
178 HYPOGLYCAEMIA 140
179 SLEEP DISORDER 138
180 AMNESIA 137
181 METABOLIC ACIDOSIS 134
182 HALLUCINATION, VISUAL 133
183 MUSCLE SPASMS 133
184 MYALGIA 133
185 NEUROTOXICITY 130
186 RESPIRATORY DISTRESS 129
187 ALOPECIA 128
188 SOPOR 128
189 HYPERGLYCAEMIA 127
190 DEPRESSED MOOD 126
191 ARTHRALGIA 125
192 SINUS TACHYCARDIA 125
193 THERAPEUTIC PRODUCT EFFECT VARIABLE 124
194 EXPOSURE DURING PREGNANCY 122
195 BLOOD PRESSURE INCREASED 121
196 DEEP VEIN THROMBOSIS 121
197 EPILEPSY 121
198 CEREBROVASCULAR ACCIDENT 120
199 TACHYPNOEA 120
200 BACK PAIN 118
201 LYMPHOCYTE COUNT DECREASED 118
202 TOXIC EPIDERMAL NECROLYSIS 118
203 PRIAPISM 117
204 BRADYKINESIA 116
205 OCULOGYRIC CRISIS 116
206 PSYCHOTIC SYMPTOM 116
207 CELLULITIS 115
208 DROOLING 114
209 HYPERSENSITIVITY 114
210 FEBRILE NEUTROPENIA 113
211 BLOOD PRESSURE DECREASED 112
212 MALIGNANT NEOPLASM PROGRESSION 112
213 OXYGEN SATURATION DECREASED 111
214 ABDOMINAL PAIN UPPER 110
215 MOVEMENT DISORDER 110
216 MYOCARDIAL INFARCTION 110
217 GENERALISED TONIC-CLONIC SEIZURE 109
218 HYPERTONIA 109
219 AGRANULOCYTOSIS 108
220 CHILLS 108
221 DYSLIPIDAEMIA 108
222 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 108
223 TYPE 2 DIABETES MELLITUS 108
224 BALANCE DISORDER 107
225 ANTICHOLINERGIC SYNDROME 106
226 COGWHEEL RIGIDITY 105
227 ILEUS PARALYTIC 104
228 PAIN IN EXTREMITY 104
229 ABDOMINAL DISTENSION 103
230 DYSPEPSIA 103
231 EATING DISORDER 103
232 EMBOLISM VENOUS 103
233 DRUG TOXICITY 102
234 EMOTIONAL DISTRESS 101
235 PANCYTOPENIA 101
236 PULMONARY OEDEMA 101
237 RESPIRATORY DEPRESSION 101
238 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 100
239 HYPERREFLEXIA 100
240 LOWER RESPIRATORY TRACT INFECTION 100
241 SUDDEN DEATH 100
242 VISUAL IMPAIRMENT 100
243 ADVERSE DRUG REACTION 99
244 RESPIRATORY ARREST 99
245 ACUTE RESPIRATORY FAILURE 98
246 DEMENTIA 98
247 DRY MOUTH 97
248 NERVOUS SYSTEM DISORDER 96
249 PERIPHERAL SWELLING 96
250 AFFECTIVE DISORDER 94
251 THERAPEUTIC RESPONSE DECREASED 94
252 VENTRICULAR FIBRILLATION 94
253 ANTIPSYCHOTIC DRUG LEVEL INCREASED 93
254 ERYTHEMA 93
255 GRANULOCYTOPENIA 93
256 MUCOSAL INFLAMMATION 93
257 MUSCLE TWITCHING 93
258 MULTIPLE ORGAN DYSFUNCTION SYNDROME 92
259 MUSCULAR WEAKNESS 92
260 PERSECUTORY DELUSION 92
261 STEVENS-JOHNSON SYNDROME 92
262 VENTRICULAR TACHYCARDIA 92
263 BLISTER 91
264 ORTHOSTATIC HYPOTENSION 90
265 APATHY 89
266 GASTROINTESTINAL HAEMORRHAGE 88
267 STUPOR 88
268 SWOLLEN TONGUE 88
269 ADVERSE EVENT 87
270 THINKING ABNORMAL 87
271 ANGIOEDEMA 86
272 LIVER FUNCTION TEST ABNORMAL 86
273 SCHIZOAFFECTIVE DISORDER 85
274 SINUS BRADYCARDIA 85
275 TORTICOLLIS 85
276 EMOTIONAL POVERTY 84
277 GASTROINTESTINAL DISORDER 84
278 AUTONOMIC NERVOUS SYSTEM IMBALANCE 83
279 BODY TEMPERATURE INCREASED 83
280 HYPOPHAGIA 83
281 LEUKAEMIA 82
282 POISONING 82
283 SOCIAL AVOIDANT BEHAVIOUR 82
284 BLOOD ALKALINE PHOSPHATASE INCREASED 81
285 BRAIN INJURY 81
286 CYANOSIS 81
287 PALPITATIONS 81
288 PERICARDIAL EFFUSION 81
289 ACCIDENTAL OVERDOSE 80
290 ASPIRATION 80
291 DELUSION OF GRANDEUR 80
292 PSYCHOMOTOR RETARDATION 80
293 SEDATION COMPLICATION 80
294 BLOOD TRIGLYCERIDES INCREASED 79
295 CARDIAC DISORDER 79
296 BLOOD PROLACTIN INCREASED 78
297 HYPERKALAEMIA 78
298 REBOUND EFFECT 78
299 HYPOTHYROIDISM 77
300 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 76
301 HEPATIC ENZYME INCREASED 76
302 PARKINSON^S DISEASE 76
303 BLOOD CHOLESTEROL INCREASED 75
304 THERAPY PARTIAL RESPONDER 75
305 BRAIN OEDEMA 74
306 HYPOAESTHESIA 74
307 ABDOMINAL DISCOMFORT 73
308 REFUSAL OF TREATMENT BY PATIENT 73
309 SHOCK 73
310 BLOOD UREA INCREASED 72
311 GASTROOESOPHAGEAL REFLUX DISEASE 72
312 SEXUAL DYSFUNCTION 72
313 CARDIOMYOPATHY 71
314 CIRCULATORY COLLAPSE 71
315 INTESTINAL OBSTRUCTION 71
316 POLYDIPSIA 71
317 PRODUCT DOSE OMISSION ISSUE 71
318 EOSINOPHILIA 70
319 HYPERSOMNIA 68
320 RASH MACULO-PAPULAR 68
321 DIABETIC KETOACIDOSIS 67
322 DRUG DEPENDENCE 67
323 MIOSIS 67
324 MUTISM 67
325 ACUTE RESPIRATORY DISTRESS SYNDROME 66
326 CHOKING 66
327 RESPIRATORY DISORDER 65
328 TRANSAMINASES INCREASED 65
329 APHASIA 64
330 EMOTIONAL DISORDER 64
331 HEPATIC FUNCTION ABNORMAL 64
332 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 64
333 MOBILITY DECREASED 64
334 MYDRIASIS 64
335 PANCREATITIS 64
336 BEHAVIOUR DISORDER 63
337 DISEASE RECURRENCE 63
338 ERECTILE DYSFUNCTION 63
339 HAEMATOCRIT DECREASED 63
340 MALIGNANT CATATONIA 63
341 METABOLIC DISORDER 63
342 BIPOLAR DISORDER 62
343 HALLUCINATIONS, MIXED 62
344 INTENTIONAL PRODUCT USE ISSUE 62
345 OEDEMA 62
346 OROPHARYNGEAL PAIN 62
347 PARAESTHESIA 62
348 PRODUCTIVE COUGH 62
349 CONTUSION 61
350 FEAR 61
351 HAEMATEMESIS 61
352 PLATELET COUNT INCREASED 61
353 ATAXIA 60
354 GYNAECOMASTIA 60
355 HYPERAMMONAEMIA 60
356 FAECALOMA 59
357 LYMPHADENOPATHY 59
358 ANGER 58
359 BLOOD SODIUM DECREASED 58
360 COLITIS ISCHAEMIC 58
361 GAMMA-GLUTAMYLTRANSFERASE INCREASED 58
362 HYPERNATRAEMIA 58
363 INTERNATIONAL NORMALISED RATIO INCREASED 58
364 RESTLESS LEGS SYNDROME 58
365 STRESS 57
366 ACUTE MYOCARDIAL INFARCTION 56
367 END STAGE RENAL DISEASE 56
368 GALACTORRHOEA 56
369 INJURY 56
370 PALLOR 56
371 ASCITES 55
372 EYE MOVEMENT DISORDER 55
373 ILEUS 55
374 LIVER DISORDER 55
375 SARS-COV-2 TEST POSITIVE 55
376 CONTRAINDICATED PRODUCT ADMINISTERED 54
377 ELECTROLYTE IMBALANCE 54
378 GASTRITIS 54
379 INCONTINENCE 54
380 LACTIC ACIDOSIS 54
381 NASOPHARYNGITIS 54
382 NEOPLASM PROGRESSION 54
383 NERVOUSNESS 54
384 RECTAL HAEMORRHAGE 54
385 RED BLOOD CELL COUNT DECREASED 54
386 RHINORRHOEA 54
387 TROPONIN INCREASED 54
388 TUBULOINTERSTITIAL NEPHRITIS 54
389 VENTRICULAR EXTRASYSTOLES 54
390 COORDINATION ABNORMAL 53
391 DYSURIA 53
392 MIGRAINE 53
393 STAPHYLOCOCCAL INFECTION 53
394 BLOOD POTASSIUM DECREASED 52
395 LYMPHOCYTE COUNT ABNORMAL 52
396 PANCREATITIS ACUTE 52
397 RENAL DISORDER 52
398 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 52
399 TRISMUS 52
400 AMENORRHOEA 51
401 ANAPHYLACTIC REACTION 51
402 BLOOD LACTATE DEHYDROGENASE INCREASED 51
403 HAEMODYNAMIC INSTABILITY 51
404 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 51
405 METABOLIC SYNDROME 51
406 NIGHTMARE 51
407 PREMATURE BABY 51
408 SWELLING FACE 51
409 CLONUS 50
410 PERICARDITIS 50
411 PULMONARY CONGESTION 50
412 RHINALGIA 50
413 TIC 50
414 ANHEDONIA 49
415 DRUG EFFECT DECREASED 49
416 DRUG-INDUCED LIVER INJURY 49
417 HEPATOCELLULAR INJURY 49
418 NO ADVERSE EVENT 49
419 OROMANDIBULAR DYSTONIA 49
420 CARDIAC FAILURE CONGESTIVE 48
421 CHEST DISCOMFORT 48
422 HEAD INJURY 48
423 HEPATITIS 48
424 BLOOD ALBUMIN DECREASED 47
425 COMA SCALE ABNORMAL 47
426 ENCEPHALITIS AUTOIMMUNE 47
427 GRAND MAL CONVULSION 47
428 HEPATOTOXICITY 47
429 HYPERVENTILATION 47
430 HYPOKINESIA 47
431 HYPOMAGNESAEMIA 47
432 LUNG DISORDER 47
433 MYOCARDIAL ISCHAEMIA 47
434 BLOOD PHOSPHORUS DECREASED 46
435 CONJUNCTIVITIS 46
436 DRUG DOSE OMISSION 46
437 GASTROENTERITIS 46
438 HAEMATURIA 46
439 HYPERAMMONAEMIC ENCEPHALOPATHY 46
440 INFLAMMATION 46
441 PSYCHIATRIC SYMPTOM 46
442 SPASMODIC DYSPHONIA 46
443 ACUTE HEPATIC FAILURE 45
444 ACUTE PSYCHOSIS 45
445 EPISTAXIS 45
446 HEPATIC FAILURE 45
447 HYPOCALCAEMIA 45
448 INCORRECT ROUTE OF DRUG ADMINISTRATION 45
449 SKIN EXFOLIATION 45
450 BLOOD BILIRUBIN INCREASED 44
451 BRADYPHRENIA 44
452 CHOLELITHIASIS 44
453 COLITIS 44
454 COVID-19 PNEUMONIA 44
455 GLOMERULAR FILTRATION RATE DECREASED 44
456 IMPAIRED GASTRIC EMPTYING 44
457 INTERSTITIAL LUNG DISEASE 44
458 RESPIRATORY TRACT INFECTION 44
459 TENSION 44
460 THROMBOSIS 44
461 WHEEZING 44
462 DISSEMINATED INTRAVASCULAR COAGULATION 43
463 ELECTROENCEPHALOGRAM ABNORMAL 43
464 GESTATIONAL DIABETES 43
465 HAEMORRHAGE 43
466 JOINT SWELLING 43
467 NECK PAIN 43
468 TONGUE DISORDER 43
469 UNEVALUABLE EVENT 43
470 UPPER RESPIRATORY TRACT INFECTION 43
471 BLINDNESS 42
472 DRUG EXPOSURE DURING PREGNANCY 42
473 HYPERCHOLESTEROLAEMIA 42
474 MULTI-ORGAN FAILURE 42
475 NEPHROGENIC DIABETES INSIPIDUS 42
476 RESPIRATORY ALKALOSIS 42
477 THERAPY CESSATION 42
478 ANGINA PECTORIS 41
479 CEREBRAL ATROPHY 41
480 CHOLESTASIS 41
481 DYSSTASIA 41
482 HYPOTONIA 41
483 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 41
484 MAJOR DEPRESSION 41
485 MOOD ALTERED 41
486 SWELLING 41
487 VENTRICULAR ARRHYTHMIA 41
488 BRUXISM 40
489 CARDIOGENIC SHOCK 40
490 COMMUNICATION DISORDER 40
491 DRUG DISPENSING ERROR 40
492 EOSINOPHIL COUNT DECREASED 40
493 EOSINOPHIL COUNT INCREASED 40
494 FEELING HOT 40
495 HEMIPARESIS 40
496 HEPATIC STEATOSIS 40
497 IMPULSIVE BEHAVIOUR 40
498 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 40
499 RESPIRATORY ACIDOSIS 40
500 SUDDEN CARDIAC DEATH 40
501 URTICARIA 40
502 ASPHYXIA 39
503 FEMORAL NECK FRACTURE 39
504 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 39
505 PARADOXICAL DRUG REACTION 39
506 POLLAKIURIA 39
507 RENAL TUBULAR NECROSIS 39
508 ABASIA 38
509 ABNORMAL WEIGHT GAIN 38
510 CHOREA 38
511 HIP FRACTURE 38
512 INFLUENZA 38
513 INJECTION SITE PAIN 38
514 KLEBSIELLA INFECTION 38
515 NEURALGIA 38
516 NO THERAPEUTIC RESPONSE 38
517 OSTEOARTHRITIS 38
518 PANIC ATTACK 38
519 PRODUCT ADMINISTRATION ERROR 38
520 SCREAMING 38
521 TINNITUS 38
522 APNOEA 37
523 CATARACT 37
524 DYSPHONIA 37
525 INCOHERENT 37
526 METASTASES TO CENTRAL NERVOUS SYSTEM 37
527 POSTURE ABNORMAL 37
528 RASH ERYTHEMATOUS 37
529 RASH MACULAR 37
530 RETCHING 37
531 ROAD TRAFFIC ACCIDENT 37
532 VERTIGO 37
533 BLOOD PROLACTIN ABNORMAL 36
534 CYTOKINE RELEASE SYNDROME 36
535 DISCOMFORT 36
536 DRUG EFFECT INCOMPLETE 36
537 LEFT VENTRICULAR DYSFUNCTION 36
538 OCULAR HYPERAEMIA 36
539 PRODUCT QUALITY ISSUE 36
540 RESPIRATORY RATE INCREASED 36
541 RESTING TREMOR 36
542 SELF INJURIOUS BEHAVIOUR 36
543 STAPHYLOCOCCAL SEPSIS 36
544 ACNE 35
545 ATRIAL FLUTTER 35
546 DRUG LEVEL DECREASED 35
547 FLUSHING 35
548 INFLUENZA LIKE ILLNESS 35
549 JAUNDICE 35
550 MUSCLE TIGHTNESS 35
551 PLASMA CELL MYELOMA 35
552 POLYURIA 35
553 SKIN LESION 35
554 STOMATITIS 35
555 THERAPEUTIC AGENT TOXICITY 35
556 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35
557 BLOOD POTASSIUM INCREASED 34
558 DEPRESSIVE SYMPTOM 34
559 DRUG LEVEL BELOW THERAPEUTIC 34
560 FRACTURE 34
561 HOT FLUSH 34
562 HYPERLIPIDAEMIA 34
563 LIVER INJURY 34
564 MOTOR DYSFUNCTION 34
565 NYSTAGMUS 34
566 PNEUMOTHORAX 34
567 TRANSIENT ISCHAEMIC ATTACK 34
568 ECONOMIC PROBLEM 33
569 FLATULENCE 33
570 GAZE PALSY 33
571 HEART RATE IRREGULAR 33
572 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 33
573 NEGATIVISM 33
574 PSYCHIATRIC DECOMPENSATION 33
575 SELF-INJURIOUS IDEATION 33
576 SLEEP APNOEA SYNDROME 33
577 AFFECT LABILITY 32
578 APRAXIA 32
579 ARTHRITIS 32
580 BRONCHITIS 32
581 BUNDLE BRANCH BLOCK RIGHT 32
582 CARDIAC FAILURE ACUTE 32
583 DRUG LEVEL ABOVE THERAPEUTIC 32
584 DYSPNOEA EXERTIONAL 32
585 ELECTROCARDIOGRAM ABNORMAL 32
586 FEELING GUILTY 32
587 FEMUR FRACTURE 32
588 HEPATIC CYTOLYSIS 32
589 MOOD SWINGS 32
590 PNEUMONITIS 32
591 POTENTIATING DRUG INTERACTION 32
592 UPPER GASTROINTESTINAL HAEMORRHAGE 32
593 ACCIDENTAL EXPOSURE 31
594 BLUNTED AFFECT 31
595 BRAIN DEATH 31
596 CEREBRAL HAEMORRHAGE 31
597 CRYING 31
598 DIABETES MELLITUS INADEQUATE CONTROL 31
599 EJECTION FRACTION DECREASED 31
600 GAIT INABILITY 31
601 HAEMOLYTIC ANAEMIA 31
602 LUNG INFILTRATION 31
603 MALNUTRITION 31
604 MOUTH ULCERATION 31
605 ORAL CANDIDIASIS 31
606 PROTRUSION TONGUE 31
607 ASTHMA 30
608 ATRIOVENTRICULAR BLOCK COMPLETE 30
609 CLOSTRIDIUM DIFFICILE COLITIS 30
610 CYSTITIS 30
611 DRUG ERUPTION 30
612 DYSPHORIA 30
613 HEART RATE DECREASED 30
614 HEPATIC ENCEPHALOPATHY 30
615 HYPERCALCAEMIA 30
616 HYPERTHYROIDISM 30
617 HYPERTRIGLYCERIDAEMIA 30
618 OLIGURIA 30
619 PERITONITIS 30
620 POOR QUALITY SLEEP 30
621 PSEUDOMONAS INFECTION 30
622 SUBSTANCE ABUSE 30
623 SUSPECTED SUICIDE 30
624 AKINESIA 29
625 ATELECTASIS 29
626 BLOOD PRESSURE SYSTOLIC INCREASED 29
627 CACHEXIA 29
628 HAEMATOCHEZIA 29
629 HYPERCAPNIA 29
630 LYMPHOPENIA 29
631 NEOPLASM MALIGNANT 29
632 NEPHROGENIC ANAEMIA 29
633 NEUTROPHILIA 29
634 RENAL INJURY 29
635 SELF-MEDICATION 29
636 STATUS EPILEPTICUS 29
637 URINE OUTPUT DECREASED 29
638 VIRAL INFECTION 29
639 ACUTE PULMONARY OEDEMA 28
640 CARDIOTOXICITY 28
641 ENCEPHALITIS 28
642 HOSTILITY 28
643 HYPERTRANSAMINASAEMIA 28
644 HYPORESPONSIVE TO STIMULI 28
645 IMMOBILE 28
646 JOINT DISLOCATION 28
647 JOINT STIFFNESS 28
648 LEFT VENTRICULAR HYPERTROPHY 28
649 PARKINSONIAN GAIT 28
650 PERIORBITAL OEDEMA 28
651 PHOTOPSIA 28
652 PULSELESS ELECTRICAL ACTIVITY 28
653 STARING 28
654 THERAPEUTIC PRODUCT EFFECT DECREASED 28
655 TOXIC ENCEPHALOPATHY 28
656 TYPE 1 DIABETES MELLITUS 28
657 UROSEPSIS 28
658 VISCERAL CONGESTION 28
659 ABORTION SPONTANEOUS 27
660 BONE MARROW FAILURE 27
661 CARDIOVASCULAR DISORDER 27
662 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 27
663 DRUG WITHDRAWAL SYNDROME NEONATAL 27
664 HYPERLACTACIDAEMIA 27
665 HYPOMANIA 27
666 ISCHAEMIA 27
667 MEGACOLON 27
668 MUSCLE CONTRACTIONS INVOLUNTARY 27
669 PAROXYSMAL PERCEPTUAL ALTERATION 27
670 PRODUCT PACKAGING ISSUE 27
671 PSORIASIS 27
672 SURGERY 27
673 ABDOMINAL PAIN LOWER 26
674 ATRIOVENTRICULAR BLOCK 26
675 BLOOD TEST ABNORMAL 26
676 BONE PAIN 26
677 CANDIDA INFECTION 26
678 DECUBITUS ULCER 26
679 EYELID OEDEMA 26
680 FLUID RETENTION 26
681 HAEMODIALYSIS 26
682 HOMICIDAL IDEATION 26
683 HYPOALBUMINAEMIA 26
684 ILL-DEFINED DISORDER 26
685 LOGORRHOEA 26
686 MULTIPLE DRUG OVERDOSE 26
687 NIKOLSKY^S SIGN 26
688 OSTEOPOROSIS 26
689 PETIT MAL EPILEPSY 26
690 RASH GENERALISED 26
691 WATER INTOXICATION 26
692 ACTIVITIES OF DAILY LIVING IMPAIRED 25
693 ANOREXIA 25
694 APHONIA 25
695 BODY TEMPERATURE DECREASED 25
696 BREAST CANCER 25
697 BUNDLE BRANCH BLOCK LEFT 25
698 COAGULOPATHY 25
699 ECHOLALIA 25
700 EYE DISORDER 25
701 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 25
702 LIVER FUNCTION TEST INCREASED 25
703 LONG QT SYNDROME 25
704 LYMPHOCYTE COUNT INCREASED 25
705 METASTASES TO LUNG 25
706 MITRAL VALVE INCOMPETENCE 25
707 PARALYSIS 25
708 SUBDURAL HAEMATOMA 25
709 THERAPEUTIC RESPONSE UNEXPECTED 25
710 UNDERDOSE 25
711 ACCIDENTAL EXPOSURE TO PRODUCT 24
712 CARDIAC DYSFUNCTION 24
713 CEREBRAL INFARCTION 24
714 DRUG ADMINISTRATION ERROR 24
715 DYSPHEMIA 24
716 FACE OEDEMA 24
717 GENERAL PHYSICAL CONDITION ABNORMAL 24
718 HYPERKINESIA 24
719 INTENTIONAL DOSE OMISSION 24
720 MUSCULOSKELETAL PAIN 24
721 ODYNOPHAGIA 24
722 PURPURA 24
723 RENAL CYST 24
724 RENAL NEOPLASM 24
725 TOXIC SKIN ERUPTION 24
726 WAXY FLEXIBILITY 24
727 AMMONIA INCREASED 23
728 AZOTAEMIA 23
729 BEDRIDDEN 23
730 CORONARY ARTERY DISEASE 23
731 DEMENTIA WITH LEWY BODIES 23
732 DERMATITIS BULLOUS 23
733 DIABETIC COMA 23
734 GENERALISED OEDEMA 23
735 HAEMORRHOIDS 23
736 HEAD TITUBATION 23
737 HYDRONEPHROSIS 23
738 HYPERPHAGIA 23
739 HYPOVENTILATION 23
740 INTESTINAL ISCHAEMIA 23
741 LIP SWELLING 23
742 NEPHROPATHY TOXIC 23
743 OPISTHOTONUS 23
744 POST-TRAUMATIC STRESS DISORDER 23
745 PRODUCT SUBSTITUTION ISSUE 23
746 RESUSCITATION 23
747 SKIN INFECTION 23
748 THIRST 23
749 TONIC CLONIC MOVEMENTS 23
750 ADENOMA BENIGN 22
751 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 22
752 ANURIA 22
753 APALLIC SYNDROME 22
754 BLOOD MAGNESIUM DECREASED 22
755 BLOOD SODIUM INCREASED 22
756 BORDERLINE PERSONALITY DISORDER 22
757 CAESAREAN SECTION 22
758 CARDIOMEGALY 22
759 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 22
760 DEVICE RELATED INFECTION 22
761 DISSOCIATION 22
762 ENURESIS 22
763 FAILURE TO THRIVE 22
764 GLYCOSYLATED HAEMOGLOBIN INCREASED 22
765 HAEMOPTYSIS 22
766 HEPATITIS ACUTE 22
767 HYPERTHERMIA MALIGNANT 22
768 ILLNESS 22
769 ILLUSION 22
770 JAW DISORDER 22
771 MULTIPLE DRUG THERAPY 22
772 ORAL DISORDER 22
773 PANCREATITIS NECROTISING 22
774 PAROTITIS 22
775 PERSONALITY CHANGE 22
776 PRODUCT PRESCRIBING ISSUE 22
777 PULSE ABSENT 22
778 SEXUALLY INAPPROPRIATE BEHAVIOUR 22
779 SKIN ULCER 22
780 TONGUE BITING 22
781 TOOTH LOSS 22
782 VENOUS THROMBOSIS LIMB 22
783 VOLVULUS 22
784 VULVOVAGINAL CANDIDIASIS 22
785 WRONG TECHNIQUE IN DRUG USAGE PROCESS 22
786 ARTHROPATHY 21
787 BACTERIAL INFECTION 21
788 BLOOD BICARBONATE DECREASED 21
789 BLOOD CALCIUM DECREASED 21
790 BRONCHOPNEUMONIA 21
791 CARDIOPULMONARY FAILURE 21
792 CENTRAL NERVOUS SYSTEM LESION 21
793 GRANDIOSITY 21
794 HOSPICE CARE 21
795 LACRIMATION INCREASED 21
796 MELAENA 21
797 MONOCYTE COUNT INCREASED 21
798 NEUTROPENIC SEPSIS 21
799 NOCTURIA 21
800 POSTURING 21
801 PRODUCT DOSE OMISSION 21
802 PULMONARY HYPERTENSION 21
803 REFUSAL OF EXAMINATION 21
804 SNORING 21
805 SPLENOMEGALY 21
806 SUPRAVENTRICULAR TACHYCARDIA 21
807 THERAPY CHANGE 21
808 THERAPY INTERRUPTED 21
809 WRONG PRODUCT ADMINISTERED 21
810 ANAL INCONTINENCE 20
811 ANAPHYLACTIC SHOCK 20
812 BLOOD GLUCOSE ABNORMAL 20
813 BLOOD LACTIC ACID INCREASED 20
814 BLOOD PRESSURE FLUCTUATION 20
815 CLOSTRIDIUM DIFFICILE INFECTION 20
816 COLONIC PSEUDO-OBSTRUCTION 20
817 DELUSIONAL DISORDER, UNSPECIFIED TYPE 20
818 DRY SKIN 20
819 ECZEMA 20
820 ELECTROCARDIOGRAM T WAVE ABNORMAL 20
821 ENDOTRACHEAL INTUBATION 20
822 FOOD POISONING 20
823 HYPERTENSIVE CRISIS 20
824 HYPOPARATHYROIDISM 20
825 HYPOREFLEXIA 20
826 INTENTIONAL DRUG MISUSE 20
827 MATERNAL EXPOSURE BEFORE PREGNANCY 20
828 METASTASES TO BONE 20
829 MYOPATHY 20
830 NORMAL NEWBORN 20
831 NUCHAL RIGIDITY 20
832 PHYSICAL ASSAULT 20
833 PITUITARY TUMOUR BENIGN 20
834 RASH PRURITIC 20
835 REDUCED FACIAL EXPRESSION 20
836 SCHIZOPHRENIA, PARANOID TYPE 20
837 SMALL INTESTINAL OBSTRUCTION 20
838 STEREOTYPY 20
839 TACHYPHRENIA 20
840 TROPONIN I INCREASED 20
841 VERBAL ABUSE 20
842 WOUND 20
843 ACUTE CORONARY SYNDROME 19
844 BLOOD GLUCOSE DECREASED 19
845 BLOOD IRON DECREASED 19
846 BONE DISORDER 19
847 CHOLECYSTITIS 19
848 CHROMATURIA 19
849 COLD SWEAT 19
850 DERMATITIS EXFOLIATIVE 19
851 DIALYSIS 19
852 DIPLOPIA 19
853 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 19
854 ENCEPHALITIS TOXIC 19
855 FULL BLOOD COUNT DECREASED 19
856 GLUCOSE TOLERANCE IMPAIRED 19
857 HEAD DISCOMFORT 19
858 HYPERBILIRUBINAEMIA 19
859 HYPERSEXUALITY 19
860 HYPOAESTHESIA ORAL 19
861 ISCHAEMIC STROKE 19
862 LOW BIRTH WEIGHT BABY 19
863 LUNG NEOPLASM MALIGNANT 19
864 MULTIPLE FRACTURES 19
865 MUSCULOSKELETAL CHEST PAIN 19
866 PROTEIN TOTAL DECREASED 19
867 SLUGGISHNESS 19
868 SPINAL COMPRESSION FRACTURE 19
869 SPUTUM DISCOLOURED 19
870 SUICIDAL BEHAVIOUR 19
871 URETERIC OBSTRUCTION 19
872 VICTIM OF CRIME 19
873 ABSCESS 18
874 ACIDOSIS 18
875 ACUTE MYELOID LEUKAEMIA 18
876 ANGIOPATHY 18
877 ANOSOGNOSIA 18
878 BLOOD CHLORIDE DECREASED 18
879 BLOOD DISORDER 18
880 CEREBRAL DISORDER 18
881 CEREBRAL ISCHAEMIA 18
882 CIRCADIAN RHYTHM SLEEP DISORDER 18
883 COMPULSIVE SEXUAL BEHAVIOUR 18
884 CONSCIOUSNESS FLUCTUATING 18
885 DENTAL CARIES 18
886 EMPHYSEMA 18
887 FACIAL PARALYSIS 18
888 FIBRIN D DIMER INCREASED 18
889 GASTROINTESTINAL NECROSIS 18
890 GRIMACING 18
891 HEPATOMEGALY 18
892 HYPERPYREXIA 18
893 INAPPROPRIATE AFFECT 18
894 INTESTINAL DILATATION 18
895 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 18
896 LABILE BLOOD PRESSURE 18
897 MYOCARDIAL REPERFUSION INJURY 18
898 ORTHOPNOEA 18
899 OSCILLOPSIA 18
900 PARAPARESIS 18
901 PELVIC FRACTURE 18
902 PERIPHERAL COLDNESS 18
903 PRESCRIBED UNDERDOSE 18
904 PRODUCT ADMINISTRATION INTERRUPTED 18
905 PRODUCT PRESCRIBING ERROR 18
906 PSYCHOMOTOR SKILLS IMPAIRED 18
907 RENAL FAILURE CHRONIC 18
908 RIB FRACTURE 18
909 SLOW SPEECH 18
910 SYMPTOM MASKED 18
911 ARTERIOSCLEROSIS 17
912 BACTERAEMIA 17
913 BIPOLAR I DISORDER 17
914 BLOOD CHOLESTEROL ABNORMAL 17
915 BLOOD URINE PRESENT 17
916 BREAST ENLARGEMENT 17
917 BURNING SENSATION 17
918 CHOLINERGIC SYNDROME 17
919 DRUG SCREEN POSITIVE 17
920 DRUG-GENETIC INTERACTION 17
921 DYSGEUSIA 17
922 ERYSIPELAS 17
923 EYE SWELLING 17
924 FAECES DISCOLOURED 17
925 GASTRIC ULCER 17
926 HUNGER 17
927 INFLAMMATORY MARKER INCREASED 17
928 METASTASES TO LIVER 17
929 MUSCLE CONTRACTURE 17
930 NEPHROLITHIASIS 17
931 OSTEOMYELITIS 17
932 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17
933 POISONING DELIBERATE 17
934 POST PROCEDURAL COMPLICATION 17
935 SINUSITIS 17
936 SKIN DISCOLOURATION 17
937 SKIN DISORDER 17
938 SOMNAMBULISM 17
939 SUBARACHNOID HAEMORRHAGE 17
940 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 17
941 UMBILICAL HERNIA 17
942 VARICOSE VEIN 17
943 WRONG PATIENT RECEIVED PRODUCT 17
944 ALCOHOL ABUSE 16
945 ANTICONVULSANT DRUG LEVEL INCREASED 16
946 BASAL CELL CARCINOMA 16
947 BRONCHOSPASM 16
948 CEREBROVASCULAR DISORDER 16
949 DECREASED ACTIVITY 16
950 DIABETIC NEUROPATHY 16
951 DIET REFUSAL 16
952 DISABILITY 16
953 DISTRACTIBILITY 16
954 DRUG CLEARANCE DECREASED 16
955 DRUG MONITORING PROCEDURE NOT PERFORMED 16
956 ELECTROCARDIOGRAM PR PROLONGATION 16
957 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 16
958 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 16
959 ELECTROCARDIOGRAM T WAVE INVERSION 16
960 EMBOLISM 16
961 GAMBLING DISORDER 16
962 GASTRIC INFECTION 16
963 HAEMATOMA 16
964 HEPATIC CIRRHOSIS 16
965 HICCUPS 16
966 HYPOGAMMAGLOBULINAEMIA 16
967 HYPOTONIA NEONATAL 16
968 IMPAIRED SELF-CARE 16
969 INITIAL INSOMNIA 16
970 KIDNEY INFECTION 16
971 LIP EROSION 16
972 LIVE BIRTH 16
973 LOCAL SWELLING 16
974 MASKED FACIES 16
975 MATERNAL DRUGS AFFECTING FOETUS 16
976 MUCOSAL DRYNESS 16
977 MULTIPLE MYELOMA 16
978 NEGLECT OF PERSONAL APPEARANCE 16
979 OBSESSIVE THOUGHTS 16
980 PENIS DISORDER 16
981 PERSONALITY DISORDER 16
982 PETECHIAE 16
983 POOR FEEDING INFANT 16
984 PRESSURE OF SPEECH 16
985 PYELONEPHRITIS 16
986 REBOUND ACID HYPERSECRETION 16
987 RENAL CELL CARCINOMA 16
988 THROMBOPHLEBITIS 16
989 VENTRICULAR HYPERTROPHY 16
990 ABNORMAL DREAMS 15
991 ACCIDENT 15
992 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 15
993 BLOOD THYROID STIMULATING HORMONE INCREASED 15
994 BREATHING-RELATED SLEEP DISORDER 15
995 CATAPLEXY 15
996 COMPLICATION ASSOCIATED WITH DEVICE 15
997 DEAFNESS 15
998 DRUG DIVERSION 15
999 DRY EYE 15